Zecuity and Breastfeeding
It is unknown whether Zecuity (sumatriptan transdermal) passes through breast milk. The active ingredient in the drug has been shown to pass through breast milk when given as an injection; however, only a small amount actually reaches the bloodstream. Although it is generally considered safe to use Zecuity while breastfeeding, talk to your healthcare provider about the potential risks that may apply to you.
Zecuity™ (sumatriptan transdermal) is a prescription migraine medication. It comes as a patch that is applied to the skin at the first signs of a migraine. It is unknown if Zecuity passes through breast milk.
Sumatriptan, the active ingredient in Zecuity, has been shown to pass through breast milk of animals and humans when given as an injection under the skin (a subcutaneous, or SC, injection). However, based on human studies, it has been estimated that very little of the medication would reach breast milk. Furthermore, because the drug is not absorbed well from the gastrointestinal tract, even less medicine would reach a nursing child's bloodstream.
The American Academy of Pediatrics considers sumatriptan compatible with breastfeeding. However, it is important to note that Zecuity is a skin patch. Studies to date have only included the active ingredient in Zecuity as a subcutaneous injection. Zecuity itself has not been studied in breastfeeding women.
You should discuss breastfeeding and Zecuity use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.